Sulfasalazine Oral Tablet 500Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Sulfasalazine: Oral tablet (500mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_384.JPG
Sulfasalazine 500mg Tab
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: WATSON 796 
Drug Image file DrugItem_1649.JPG
Sulfasalazine 500mg Tab
Greenstone Ltd
Pill Identification: G 500 
Drug Image file DrugItem_16565.JPG
Sulfazine 500mg Tab
Qualitest Pharmaceuticals Inc
Pill Identification: 5904 V 

What is this Medicine?

SULFASALAZINE (sul fa SAL a zeen) is used to treat ulcerative colitis.

Similar Brand Name Drugs : Azulfidine: Oral tablet (500mg)
CVS Pharmacy Patient Statistics for Sulfasalazine: Oral tablet(500mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Sulfasalazine 500mg Tablet

NDC: 005910796
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Rheumatoid Arthritis, Ulcerative Colitis

Sometimes used for but not FDA approved for the following conditions:
Crohn's Disease

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Sulfasalazine 500mg Tablet
Drug Image file DrugItem_384.JPG
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: WATSON 796 
Shape: round
Color: yellow

Reported Side Effects for Sulfasalazine 500mg Tablet

Hives Incidence:
<3.3%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
<13.0%*
Severity: MILD
Onset: EARLY
Diuresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Cyanosis Incidence:
<3.3%*
Severity: SEVERE
Onset: EARLY
Low Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hemolytic Anemia Incidence:
<3.3%*
Severity: SEVERE
Onset: DELAYED
Enlarged Thyroid Gland Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<4.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
8.0-33.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
9.0-33.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
13.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
19.0-33.0%*
Severity: MILD
Onset: EARLY
Low Sperm Count Incidence:
33.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
33.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Sulfasalazine

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.